SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on August 11, 2020. The filing serves to announce the consolidated financial results for the fourth quarter and the full fiscal year ended May 31, 2020. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1), which is not part of the input text provided for analysis.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. It only confirms the issuance of results for the fourth quarter and full fiscal year 2020.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The document explicitly states that the information in the press release is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation (Ticker: LNDC), as the input metadata incorrectly referenced Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (the press release) to obtain actual financial figures for Q4 and FY 2020, as they are absent from the 8-K cover text.
- Confirm the fiscal year-end date of May 31, 2020 when comparing results to other calendar-year companies.
- Note that the press release content is furnished but not "filed" under Section 18 of the Exchange Act, which may impact liability standards.